Evolent Health, Inc (NYSE:EVH - Get Free Report) President Daniel Joseph Mccarthy sold 65,892 shares of the firm's stock in a transaction dated Wednesday, August 26th. The shares were sold at an average price of $5.00, for a total value of $329,460.00. Following the sale, the president directly owned 655,133 shares in the company, valued at approximately $3,275,665. The trade was a 9.14% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Evolent Health Price Performance
EVH opened at $4.61 on Friday. The firm has a market capitalization of $521.21 million, a PE ratio of -1.01 and a beta of 0.79. The company has a debt-to-equity ratio of 2.52, a current ratio of 1.24 and a quick ratio of 1.24. The business's 50-day moving average is $4.78 and its two-hundred day moving average is $3.84. Evolent Health, Inc has a 1 year low of $2.10 and a 1 year high of $10.08.
Evolent Health (NYSE:EVH - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The technology company reported $0.02 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.03. Evolent Health had a negative net margin of 24.08% and a negative return on equity of 4.27%. The business had revenue of $484.50 million during the quarter, compared to analyst estimates of $597.70 million. During the same period in the prior year, the firm posted ($0.10) earnings per share. The company's quarterly revenue was up 46.9% on a year-over-year basis. Research analysts anticipate that Evolent Health, Inc will post -0.25 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Evolent Health
Several hedge funds have recently modified their holdings of the stock. R Squared Ltd acquired a new stake in Evolent Health in the 1st quarter worth approximately $26,000. CIBC Private Wealth Group LLC increased its stake in Evolent Health by 4,000.0% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 4,100 shares of the technology company's stock valued at $35,000 after purchasing an additional 4,000 shares in the last quarter. California State Teachers Retirement System increased its stake in Evolent Health by 41.7% during the 2nd quarter. California State Teachers Retirement System now owns 8,471 shares of the technology company's stock valued at $46,000 after purchasing an additional 2,494 shares in the last quarter. Strs Ohio purchased a new position in shares of Evolent Health in the first quarter worth $47,000. Finally, Vise Technologies Inc. acquired a new stake in shares of Evolent Health during the fourth quarter worth $50,000.
Analyst Ratings Changes
EVH has been the subject of a number of analyst reports. TD Cowen increased their target price on shares of Evolent Health from $5.00 to $6.00 and gave the company a "buy" rating in a research report on Monday, August 17th. Canaccord Genuity Group cut their price target on shares of Evolent Health from $7.00 to $6.00 and set a "buy" rating on the stock in a report on Monday, August 10th. JPMorgan Chase & Co. upped their price target on Evolent Health from $5.00 to $6.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 18th. Truist Financial decreased their price objective on Evolent Health from $7.00 to $6.00 and set a "hold" rating for the company in a report on Wednesday, August 12th. Finally, Weiss Ratings cut Evolent Health from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Tuesday, August 18th. Eleven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $5.96.
Check Out Our Latest Stock Analysis on EVH
Evolent Health Company Profile
(
Get Free Report)
Evolent Health, Inc is a U.S.-based healthcare technology and services company that partners with health systems, physician organizations and health plans to design, build and operate value-based care programs. Headquartered in Arlington, Virginia, the company was founded in 2011 as a joint venture between TPG and the University of Pittsburgh Medical Center (UPMC). Evolent Health aims to help its clients transition from fee-for-service payment models to value-based care arrangements by leveraging its proprietary technology platforms and clinical expertise.
The company's core offerings include care management solutions, population health analytics and clinical advisory services.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
